The Pharmacy Times® Coronavirus Disease Resource Center is a comprehensive resource for clinical news and expert insights on COVID-19, an infectious disease caused by the SARS-CoV-2 virus, including vaccine information and treatments for the disease.
April 9th 2025
Monetary incentives to receive a COVID-19 vaccine at a public vaccination event may have inadvertently turned away others from receiving a booster, emphasizing the importance of recognizing spillover in trials addressing vaccine hesitancy.
April 4th 2025
The poll also showed that social media and general media coverage influenced about 33% of participants to not get vaccinated.
March 31st 2025
Pharmacists play a key role in COVID-19 management by educating patients on treatment, monitoring drug interactions, promoting vaccination, and addressing hesitancy.
March 25th 2025
As the COVID-19 pandemic moves into an endemic phase, the major impacts on drug research, collaboration, and use of new technologies due to the spread of the virus warrant recognition.
March 25th 2025
A district leader at CVS Health emphasizes that patients should get tested, be up to date with immunizations, and staying home and reach out to health care professionals when experiencing symptoms.
Pneumococcal Disease Prevention for Older Adults and the Pharmacist’s Role in an Evolving Vaccine Landscape
1.0 Credit / Immunization, Infectious Diseases
View More
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Ac...
1.5 Credits / HIV/AIDS, Infectious Diseases
View More
Immunizations Update 2024: Advancing the Role of the Pharmacy Technician in Vaccine Administration
1.0 Credit / Immunization
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
The Role of the Pharmacist in Influenza Prevention for At-Risk Adults: Strategies to Enhance Immunization
1.5 Credits / Infectious Diseases
View More
Exploring Immunizations Updates and Strategies for Addressing Vaccine Hesitancy
1.0 Credit / Immunization
View More
The Essential Role of Pharmacists in Improving Influenza Vaccination Coverage: Strategies to Increase Vaccine ...
1.0 Credit / Immunization, Infectious Diseases
View More
The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake
1.0 Credit / Immunization, Infectious Diseases, Pulmonology
View More
Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Ri...
1.0 Credit / Immunization, Infectious Diseases
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharma...
0.5 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion (Pharmacy Technicia...
0.75 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion
0.75 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy...
0.5 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part...
0.5 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)
0.5 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1...
0.5 Credit / Immunization
View More
Exploring HIV Long-Acting Injectable Uptake: How Pharmacists Can Encourage Long-Acting Injectables to Stem the...
1.5 Credits / HIV/AIDS, Infectious Disease
View More
Beyond the Spots: Management of Measles
1.0 Credit / Infectious Disease, Immunization
View More
Potential COVID-19 Treatment Granted Orphan Drug Status
March 25th 2020While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.
Read More
FDA Takes Action to Increase US Supplies of PPE, Devices to Combat COVID-19
March 25th 2020The FDA released a statement on taking action to increase US supplies to support the response to the coronavirus disease 2019 by providing instructions to manufacturers importing personal protective equipment and other devices.
Read More
AI Turns Coughing Sounds into Health Data for Flu, Pandemic Forecasting
March 25th 2020The new edge-computing platform may expand the arsenal of health surveillance tools used to forecast seasonal flu and other viral respiratory outbreaks, such as COVID-19 or severe acute respiratory syndrome.
Read More
COVID-19 Workers to Be Provided With Training to Protect Own Health
March 25th 2020The program will award grants for training and development of educational resources for employees in high risk occupations who serve the public during emergencies and who need skills to protect their own health.
Read More
Pennsylvania Lifts Regulation on Pharmacies for Telemedicine, Receiving Goods from Out-of-State
March 24th 2020Pennsylvania Governor Tom Wolf’s administration has decided that in-state and out-of-state health care providers can treat patients via telemedicine during the coronavirus disease 2019 pandemic.
Read More
US Pharmacopeia Providing Support to COVID-19 Vaccine, Antiviral Drug Developers
March 23rd 2020The US Pharmacopeia (USP) is providing free technical assistance to developers of antiviral drugs and vaccines that will support the public health response to the coronavirus disease 2019 (COVID-19) pandemic.
Read More
US Clinicians Warn Public to 'Stay Calm, Be Prepared' in Recent COVID-19 Survey
March 20th 2020More than 90% of physicians, nurses, and pharmacists are concerned about COVID-19 affecting their patients, whereas 68% of doctors and 67% of nurses feel they are reasonably prepared for a COVID-19 outbreak in their area.
Read More
FDA Advises Patients on Use of Non-Steroidal Anti-Inflammatory Drugs for COVID-19
March 20th 2020The FDA has released a statement addressing the issue, stating that the organization is “not aware of scientific evidence connecting the use of NSAIDs, like ibuprofen, with worsening COVID-19 symptoms.”
Read More
2 Commerce Drive
Cranbury, NJ 08512